ANI PHARMACEUTICALS INC — Director's Dealing 2018

Apr 10, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ANI PHARMACEUTICALS INC (ANIP)
CIK: 0001023024
Period of Report: 2018-04-06

Reporting Person: Marken James G. (SVP Ops & Prod Dev)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-04-06	Common Stock	A	4400	—	Acquired	69592	Direct
2018-04-07	Common Stock	F	144	$57.06	Disposed	69448	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-04-06	Stock Options	$57.06	A	5300	Acquired	2028-04-05	Common Stock (5300)	Direct

Footnotes

F1: The restricted stock and the stock options vests, and are exercisable, in equal annual installments on the first, second, third and fourth anniversaries of the grant date.

F2: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of restricted stock, which was previously reported.